The MUSCAT study: a Multicenter PROBE Study Comparing the Effects of Angiotensin II Type-1 Receptor Blockers on Self-Monitored Home Blood Pressure in Patients with Morning Hypertension: study design and background characteristics.

Published on Jan 1, 2008in Hypertension Research2.941
· DOI :10.1291/HYPRES.31.51
Haruhito Uchida3
Estimated H-index: 3
(Okayama University),
Yoshio Nakamura12
Estimated H-index: 12
(Okayama University)
+ 3 AuthorsHirofumi Makino98
Estimated H-index: 98
(Okayama University)
Sources
Abstract
The MUSCAT Study: A Multicenter PROBE Study Comparing the Effects of Angiotensin II Type-1 Receptor Blockers on Self-Monitored Home Blood Pressure in Patients with Morning Hypertension: Study Design and Background Characteristics
📖 Papers frequently viewed together
77 Citations
References46
Newest
#1Bettina Fuchs (Goethe University Frankfurt)H-Index: 2
Last. Ernst Mutschler (Goethe University Frankfurt)H-Index: 50
view all 8 authors...
The angiotensin II antagonistic effects of candesartan and losartan were compared in-vivo after single and repeated doses. Effects were related to antagonistic activity in plasma. In this double-blind, crossover study, 12 healthy male volunteers received, in random order, daily oral doses of 8 mg candesartan cilexetil or 50 mg losartan for seven days. On day 1 and day 8, dynamics and kinetics were assessed up to 48 h after dosing. Antagonistic effect was determined from the antagonist-induced ri...
23 CitationsSource
#1Giuseppe Schillaci (University of Perugia)H-Index: 63
#2Matteo Pirro (University of Perugia)H-Index: 58
Abstract Mild elevations in C-reactive protein concentration predict myocardial infarction, stroke, and vascular death in a variety of clinical settings. Despite the lack of specific evidence that C-reactive protein levels are independently associated with cardiovascular risk in patients with hypertension, the prognostic value of C-reactive protein has proven to be complementary to that of blood pressure values. Recent epidemiological evidence has indicated a link between hypertension and increa...
67 CitationsSource
#1Satoshi Morimoto (Kansai Medical University)H-Index: 8
#2Yutaka YanoH-Index: 30
Last. Katsunori SawadaH-Index: 3
view all 4 authors...
It is known that the angiotensin receptor blockers (ARBs) have organ protective effects in patients with heart failure or renal impairment. Several studies have revealed that the ARB telmisartan has an organ protective effect, but there have been few studies directly comparing the effects of telmisartan and calcium antagonists, since most clinical studies on telmisartan have been conducted in treated patients or patients on combination therapy. The present study was conducted to compare the rena...
78 CitationsSource
#1Kailash Prasad (U of S: University of Saskatchewan)H-Index: 50
C-reactive protein (CRP) plays a role in the pathogenesis of cardiovascular disease. It is a marker and predictor of cardiovascular disease. CRP possesses numerous cardiovascular effects (clotting, generation of oxygen radicals, increase in the expression of adhesion molecules and plasminogen activator inhibitor-1, plaque destabilization) that could result in cardiovascular disease. This review describes the effects of various cardiovascular drugs on the levels of CRP in health and disease. Cycl...
278 CitationsSource
314 Citations
#1Tetsuya Nakamura (Gunma University)H-Index: 10
#2Shigeki FujiiH-Index: 1
Last. Masahiko Kurabayashi (Gunma University)H-Index: 75
view all 7 authors...
Angiotensin II plays a key role in the development of vascular disease. We examined the long-term effects of selective angiotensin II receptor (ATR) blockade with valsartan on arterial wall stiffness. Brachial to ankle pulse wave velocity (baPWV) was measured in 28 women and 25 men with hypertension (mean age: 62±2 years). The measurements were repeated after 24 weeks of treatment with valsartan, 40 to 160 mg/day, with (n=10) or without (n=36) concomitant statin therapy. By multiple regression a...
27 CitationsSource
#1Takayoshi Ohkubo (Tohoku University)H-Index: 100
#2Masahiro Kikuya (Tohoku University)H-Index: 68
Last. Yutaka Imai (Tohoku University)H-Index: 95
view all 10 authors...
Objectives We sought to investigate the prognosis in subjects with “white-coat” hypertension (WCHT) and “masked” hypertension (MHT), in which blood pressure (BP) is lower in clinical measurements than during ambulatory monitoring. Background The prognostic significance of WCHT remains controversial, and little is known about MHT. Methods We obtained 24-h ambulatory BP and “casual” BP (i.e., obtained in clinical scenarios) values from 1,332 subjects (872 women, 460 men) ≥40 years old in a represe...
743 CitationsSource
#1Joji IshikawaH-Index: 43
#2Kazuomi KarioH-Index: 92
Last. Kazuyuki ShimadaH-Index: 19
view all 11 authors...
Background Morning blood pressure (BP) surge in ambulatory BP monitoring was a risk factor for stroke in our previous study. We studied the determinants of the morning minus evening systolic BP difference (ME difference) in self-measured BP monitoring, as a possible risk factor for stroke in medicated hypertensive patients. Methods Nine hundred sixty-nine hypertensive outpatients receiving stable antihypertensive drug treatment were studied using self-measured BP monitoring in the morning and ev...
91 CitationsSource
#1Thomas J. WangH-Index: 125
#2Jane C. Evans (NIH: National Institutes of Health)H-Index: 64
Last. Ramachandran S. Vasan (BU: Boston University)H-Index: 187
view all 8 authors...
Background— It has been postulated that glomerular hyperfiltration and endothelial dysfunction are early features of essential hypertension that may antedate blood pressure elevation. Microalbuminuria, a marker of glomerular hyperfiltration and endothelial dysfunction, has been described in individuals with established hypertension, but its role as a biomarker of preclinical stages of this disease has not been investigated prospectively. Methods and Results— We examined the association between u...
285 CitationsSource
#1Takuya Nishimura (Tohoku University)H-Index: 6
#2Junichiro Hashimoto (Tohoku University)H-Index: 59
Last. Yutaka Imai (Tohoku University)H-Index: 95
view all 8 authors...
Our objective was to compare the efficacy and duration of action of 4 angiotensin II receptor blockers (ARBs)—losartan (25–100 mg), candesartan (2–12 mg), valsartan (40–80 mg), and telmisartan (10–40 mg)—in patients with essential hypertension using self-measurement of blood pressure at home (home BP) and to examine the differential effect of the four ARBs on home pulse pressure (home PP). After a 2-week run-in period, each of the 4 ARBs was assigned to subjects who were diagnosed as having hype...
52 CitationsSource
Cited By7
Newest
#1Yuki Kakio (Okayama University)H-Index: 6
#2Haruhito A. UchidaH-Index: 15
Last. Jun WadaH-Index: 63
view all 7 authors...
BackgroundOlmesartan and azilsartan, angiotensin II receptor blockers (ARBs), are expected to decrease blood pressure more than the other ARBs. We conducted randomized-controlled trials to compare the practical efficacy of olmesartan with azilsartan.MethodsEighty-four patients treated with the conve
1 CitationsSource
#1F. Wilford Germino (Rush Medical College)H-Index: 1
The influence and impact of sustained high blood pressure on cardiovascular risk and chronic kidney disease is well recognized and accepted. Similarly, white-coat hypertension, while also being well described, is generally accepted as exhibiting greater risk than normotension. More recently, the identification of masked hypertension (reverse white-coat hypertension using older terminology) has added to the complexity of the hypertensive phenotype, as one may no longer simply rely upon office blo...
Source
#1Josep Redon (University of Valencia)H-Index: 85
#2Grzegorz BiloH-Index: 41
Last. Gianfranco ParatiH-Index: 122
view all 3 authors...
AbstractSURGE 2, a large-scale, practice-based study in 10 countries, evaluated the effects of telmisartan alone or with hydrochlorothiazide (HCTZ) on morning (06:00–11:59) home blood pressure (HBP) control. Hypertensive patients (clinic blood pressure [BP] ≥ 140/90 mmHg) received telmisartan 40 or 80 mg either alone or in combination with HCTZ 12.5 mg for 8 weeks. Treatment could be adjusted if clinic BP remained ≥ 140/90 mmHg. Clinic BP was measured in the morning prior to medication, and seat...
3 CitationsSource
#1Naeti Suksomboon (MU: Mahidol University)H-Index: 18
#2Nalinee Poolsup (SU.: Silpakorn University)H-Index: 18
Last. T Prasit (MU: Mahidol University)H-Index: 1
view all 3 authors...
Summary What is known and Objective: Telmisartan is an angiotensin receptor blocker (ARB) originally developed for the treatment of hypertension. It can also partially activate peroxisome proliferator-activated receptor (PPAR)-γ, which may improve insulin sensitivity. This effect may prove useful in hypertensive patients with insulin resistance or diabetes mellitus. Such activity is more marked than that observed with other ARBs. This systematic review and meta-analysis evaluated the benefit of ...
35 CitationsSource
#1Rajiv Agarwal (IU: Indiana University)H-Index: 85
#2Jennifer E. Bills (IU: Indiana University)H-Index: 5
Last. Robert P. Light (IU: Indiana University)H-Index: 28
view all 4 authors...
Hypertension remains the most common modifiable cardiovascular risk factor, yet hypertension control rates remain dismal. Home blood pressure (BP) monitoring has the potential to improve hypertension control. The purpose of this review was to quantify both the magnitude and mechanisms of benefit of home BP monitoring on BP reduction. Using a structured review, studies were selected if they reported either changes in BP or percentage of participants achieving a pre-established BP goal between ran...
263 CitationsSource
#1Haruhito A. UchidaH-Index: 15
#2Yoshio Nakamura (Okayama University)H-Index: 12
Last. Hirofumi MakinoH-Index: 98
view all 9 authors...
Aims/Introduction: The combination of hypertension with diabetes mellitus (DM) has been recognized as a critical risk factor for cardiovascular disease (CVD). We investigated the blood pressure levels in hypertensive patients with DM (HDM patients) compared with those without DM (HnDM patients). Furthermore, we examined the effect of risk factors, including chronic kidney disease (CKD) and stroke, on the management of both office blood pressure (OBP) and morning home blood pressure (MHBP). Mater...
Source
Background and objectives: Poor hypertension control observed in patients with chronic kidney disease (CKD) may in part be due to the suboptimal assessment of BP with clinic BP measurements alone. The goal of this meta-analysis was to estimate the prevalence and determinants of white-coat and masked hypertension in the adult CKD population. Design, setting, participants, & measurements: Articles reporting prevalence of masked and white-coat hypertension in patients with CKD were obtained from tw...
141 CitationsSource